Abstract
While “new therapies” are currently causing disruptions when it comes to standard cancer treatment procedures, a pharmacologist and a psychiatrist are questioning the resulting changes when it comes to the quality of care relationship. The various dosage forms are a component, in particular the subcutaneous format, which may provide an opportunity to improve the quality of life for patients during the different phases of treatment, but which will affect the rate and the timings in the structure of the care given.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
